Search
Cencora Inc
CORAdd to Watchlist
305.030USD
+4.450+1.48%
Close 07-23 16:00（ET）Quotes delayed by 15 min
59.35BMarket Cap
23.26P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-23The current earnings forecast score of Cencora Inc is 8.13, ranking 66 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 397.50, with a high of 417.00 and a low of 279.21.
Analyst Rating
Based on
16
analysts
Buy
Current Rating
352.426
Target Price
+16.29%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Cencora Inc
COR
16
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Cencora Inc's expected revenue for the next quarter?
Cencora Inc's expected revenue is 84.31B.
What is Cencora Inc's price target?
Analysts forecast that Cencora Inc's price target is USD 397.50, with the highest forecast at USD 417.00 and the lowest forecast at USD 279.21.
How have Cencora IncCOR's recent earnings per share performed?
The market expectation was USD 8.44, while Cencora IncCOR's earnings per share (EPS) for the previous quarter was USD 2.88. EPS for the next quarter is expected at USD 4.35.
What is the analyst rating for Cencora Inc?
Based on the ratings of Cencora Inc's stock from 16 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.